In Ethiopia, a pilot study on SMA through private pharmacies demonstrates high demand from women and interest from pharmacies in providing women with medication abortion, but Ethiopia’s legal framework presents challenges to a pharmacy-based model.
In forcibly displaced populations, a new study protocol outlines a community-facility capture-recapture approach to better estimate maternal deaths due to abortion complications, helping strengthen measurement where official data is incomplete.
In the Democratic Republic of Congo, research shows that misoprostol was available in less than 50% of pharmacies and mifepristone and misoprostol in less than 2% of surveyed sites. Mystery client interactions reveal that most pharmacists need training on medication abortion counseling and regimens.
In India, a trend analysis shows a substantial increase in self-managed abortion (SMA) with pills between 2014 and 2021 and demonstrates the transformative power of SMA in increasing access to safe and effective abortion.
For over 50 years, Ipas has worked to ensure that reproductive health care, including abortion and contraception, are available and accessible to all. In this report, we’re proud to share some of the key impacts of our work in 2024.
